Alector (ALEC) EBITDA Margin (2018 - 2026)
Alector (ALEC) reported EBITDA Margin of 2217.97% for Q1 2026, down 111452.0% year-over-year from N/an in Q1 2025, and down 270.89% quarter-over-quarter from 598.01% in Q4 2025.
Alector (ALEC) EBITDA Margin (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of EBITDA Margin data on file, last reported at 2217.97% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 2217.97%, down 111452.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 682.43% (down 54337.0% YoY), and the FY2025 annual result was 679.61%, down 56130.0% from the prior year.
- EBITDA Margin declined to 2217.97% in Q1 2026 per ALEC's latest filing, from 598.01% in the prior quarter.
- Over five years, EBITDA Margin peaked at 9.51% in Q2 2022 and troughed at 2217.97% in Q1 2026.
- A 5-year average of 469.48% and a median of 266.81% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2026: EBITDA Margin jumped 107980 bps in 2022, then tumbled 111452 bps in 2026.
- A 5-year view of EBITDA Margin shows it stood at 348.07% in 2022, then increased by 23 bps to 266.81% in 2023, then jumped by 98 bps to 5.06% in 2024, then sank by 11721 bps to 598.01% in 2025, then sank by 271 bps to 2217.97% in 2026.
- Business Quant data shows ALEC's EBITDA Margin at 2217.97% in Q1 2026, 598.01% in Q4 2025, and 1060.31% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -2,217.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,217.97% |
| Dec 31, 2025 | -598.01% |
| Sep 30, 2025 | -1,060.31% |
| Jun 30, 2025 | -388.86% |
| Mar 31, 2025 | -1,103.46% |
| Dec 31, 2024 | -5.06% |
| Sep 30, 2024 | -265.08% |
| Jun 30, 2024 | -257.86% |
| Mar 31, 2024 | -230.71% |
| Dec 31, 2023 | -266.81% |
| Sep 30, 2023 | -480.95% |
| Jun 30, 2023 | 3.89% |
| Mar 31, 2023 | -262.74% |
| Dec 31, 2022 | -348.07% |
| Sep 30, 2022 | -314.21% |
| Jun 30, 2022 | 9.51% |
| Mar 31, 2022 | -194.53% |
| Dec 31, 2021 | -403.82% |
| Sep 30, 2021 | 69.27% |
| Jun 30, 2021 | -842.78% |